Julie Clark is Chief Medical Officer at Adverum Biotechnologies, Inc. (ADVM). They have made 1 open-market trade across 1 company since 2021, most recently 2021-09-30.
CIK 0001865738
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADVM | 164,723 | $718K |
Shares reported on the most recent Form 4, priced at the 2021-10-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADVM | SELL | 2021-09-30 | 2021-10-04 | $2.17 | $10K | -11.7% | -3.8% | -19.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.